Atea Pharmaceuticals, Inc. (AVIR)
3.14
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 12:59
Atea Pharmaceuticals Total Liabilities (Quarterly): 27.18M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 91.08B |
| AbbVie, Inc. | 136.50B |
| KORU Medical Systems, Inc. | 10.64M |
| Erasca, Inc. | 72.52M |
| Coya Therapeutics, Inc. | 4.758M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 342.96M |
| Shareholders Equity (Quarterly) | 315.78M |
| Debt to Equity Ratio | 0.0033 |
| Current Ratio | 16.66 |
| Net Debt Paydown Yield | 0.09% |